retatrutide clinical trial dosage Phase III study demonstrates 30% weight loss retatrutide clinical trial us Dosing:

The prolonged presence of irritating compounds in the stomach, combined with the medication's effects on gastric motility, can lead to increased cramping, bloating, or general abdominal discomfort in some cases

Most studies indicate that these medications must be taken long term, as weight is easily regained once treatment stops

Because protein is so central to what GLP-1 consumers are looking for, and Oikos already had high protein yogurt offerings, it was probably easy for Danone to slightly reformulate existing products to create a new product, and market their existing products as GLP-1 friendly

However, exposure to temperatures exceeding 30C or direct heat sources (such as radiators, direct sunlight, or hot vehicles) can potentially reduce the medication's effectiveness